Cite
Ferreri F, Guerra A, Vollero L, et al. TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study. Front Aging Neurosci. 2021;13:737281doi: 10.3389/fnagi.2021.737281.
Ferreri, F., Guerra, A., Vollero, L., Ponzo, D., Määtta, S., Könönen, M., Vecchio, F., Pasqualetti, P., Miraglia, F., Simonelli, I., Corbetta, M., & Rossini, P. M. (2021). TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study. Frontiers in aging neuroscience, 13737281. https://doi.org/10.3389/fnagi.2021.737281
Ferreri, Florinda, et al. "TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study." Frontiers in aging neuroscience vol. 13 (2021): 737281. doi: https://doi.org/10.3389/fnagi.2021.737281
Ferreri F, Guerra A, Vollero L, Ponzo D, Määtta S, Könönen M, Vecchio F, Pasqualetti P, Miraglia F, Simonelli I, Corbetta M, Rossini PM. TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study. Front Aging Neurosci. 2021 Nov 22;13:737281. doi: 10.3389/fnagi.2021.737281. eCollection 2021. PMID: 34880743; PMCID: PMC8645846.
Copy
Download .nbib